1 Gross RW,Han XL.Lipidomics at the interface of structure and function in systems biology[J].Chem Biol,2011,18(3):284-291. 2 Han X.Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry:a bridge to lipidomics[J].Lipid Res,2003,44(6):1071-1079. 3 Chen S,Wang C,Cui A,et al.Development of a genetic and clinical data-based(GC)risk score for predicting survival of hepatocellular carcinoma patients after tumor resection[J].Cell Physiol Biochem,2018,48(2):491-502. 4 You JC,Jie Y,Fang RP,et al.Analysis of phosphatidylcholines(PCs)and lysophosphatidylcholines(Lyso PCs)in metastasis of breast cancer cells[J].PIBB,2015,42(6):563-573. 5 Lim S,Bang DY,Rha KH,et al.Rapid Screening of phospholipid biomarker candidates from prostate cancer urine samples by multiple reaction monitoring of uplc-esi-ms/ms and statistical approaches[J].Bull Korean Chem Soc,2014,35(35):1133-1138. 6 Provenzale D,Gupta S,Ahnen DJ,et al.Genetic/Familial high-risk assessment:colorectal version 12016,NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc Netw,2016,14(8):1010-1030. 7 Yang J,Du XL,Li ST,et al.Characteristics of differently located colorectal cancers support proximal and distal classification:a population-based study of 57,847 patients[J].PLoS One,2016,11(12):e0167540. 8 Schex R,Lieb VM,Jiménez VM,et al.HPLC-DAD-APCI/ESI-MS analysis of carotenoids and α-tocopherol in Costa Rican Acrocomia aculeata fruits of varying maturity stages[J].Food Res Int,2018,105(4):645-653. 9 Li Y,Wang C,Li D,et al.1H-NMR-based metabolic profiling of a colorectal cancer ct-26 lung metastasis model in mice[J].Oncol Rep,2017,38(5):3044-3054. 10 Kühn C,Von Oesen T,Herz C,et al.In vitro determination of protein conjugates in human cells by lc-esi-ms/ms after benzyl isothiocyanate exposure[J].J Agric Food Chem,2018,66(26):6727-6733. 11 Shao Y,Zhu B,Zheng R,et al.Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery[J].J Proteome Res,2015,14(2):906-916. 12 Hejazi L,Ebrahimi D,Guilhaus M.Determination of the composition of fatty acid mixtures using gc x fi-ms:a comprehensive two-dimensional separation approach[J].Anal Chem,2009,81(4):1450-1458. 13 Ravu RR,Jacob MR,Jeffries C,et al.LC-MS and(1)H NMR spectroscopy-guided identification of antifungal diterpenoids from sagittaria latifolia[J].J Nat Prod,2015,78(9):2255-2259. 14 Zhao J,Khan IA,Combrinck S,et al.H-NMR and UPLC-MS metabolomics:functional tools for exploring chemotypic variation in sceletium tortuosum from two provinces in South Africa[J].Phytochemistry,2018,152(2):191-203. 15 Moco S,Vervoort J,Moco S,et al.Metabolomics technologies and metabolite identification[J].Trends Anal Chem,2007,26(9):855-866. 16 Gramatyka M,Skorupa A.Nuclear magnetic resonance spectroscopy reveals metabolic changes in living cardiomyocytes after low doses of ionizing radiation[J].Acta Biochim Pol,2018,65(2):309-318. 17 Gross S,Barmet C,Dietrich BE,et al.Dynamic nuclear magnetic resonance field sensing with part-per-trillion resolution[J].Nat Commun,2016,7(3):13702. 18 Whitfield PD,German AJ,Noble PJ.Metabolomics:an emerging post-genomic tool for nutrition[J].Br J Nutr,2004,92(4):549-555. 19 Cistola DP.Compact NMR relaxometry of human blood and blood components[J].Trends Analyt Chem,2016,83(A):53-64. 20 Zhang S,Nagana Gowda GA,Ye T,et al.Advances in NMR-based biofluid analysis and metabolite profiling[J].Analyst,2010,135(7):1490-1498. 21 Ebrahimi F,Ibrahim B,Teh CH,et al.NMR-based plasma metabolomic discrimination for male fertility assessment of rats treated with eurycoma longifolia extracts[J].Syst Biol Reprod Med,2017,63(3):179-191. 22 Rochfort S,Ezernieks V,Mele P.NMR metabolomics for soil analysis provide complementary,orthogonal data to MIR and traditional soil chemistry approaches--a land use study[J].Magn Reson Chem,2015,53(9):719-725. 23 Notarnicola M,Altomare DF,Correale M,et al.Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases[J].Oncology,2005,68(4-6):371-374. 24 顾汉信.血清总胆固醇和高密度脂蛋白及其比值与结肠癌临床分期的相关性[J].苏州大学学报,2009,29(5):974-975. 25 Kühn T,Floegel A,Sookthai D,et al.Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study[J].BMC Med,2016,14(1):1-9. 26 Kondo Y,Nishiumi S,Shinohara M,et al.Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry[J].Biomark Med,2011,5(4):451-460. 27 Ritchie SA,Ahiahonu PW,Jayasinghe D,et al.Reduced levels of hydroxylated,polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients:implications for early screening and detection[J].BMC Med,2010,8(4):13. 28 王晓学,汪建平,饶本强,等.CRC患者与健康人群粪便菌群及代谢产物的差异性研究[J].中华胃肠外科杂志,2015,18(11):1106-1110. 29 Wang W,Feng B,Li X,et al.Urinary metabolic profiling of colorectal carcinoma based on online affinity solid phase extraction-high performance liquid chromatography and ultra performance liquid chromatography-mass spectrometry[J].Mol Biosyst,2010,6(10):1947-1955. 30 Tian Y,Xu T,Huang J,et al.Tissue metabonomic phenotyping for diagnosis and prognosis of human colorectal cancer[J].Sci Rep,2016,6(3):20790. |